ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 104 filers reported holding ADICET BIO INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $101,710 | +3692.3% | 17,658 | +5786.0% | 0.00% | – |
| Q4 2022 | $2,682 | -99.8% | 300 | -99.7% | 0.00% | -100.0% |
| Q3 2022 | $1,619,000 | -11.2% | 113,834 | -8.9% | 0.01% | -25.0% |
| Q2 2022 | $1,824,000 | -77.1% | 124,900 | -68.6% | 0.01% | -75.0% |
| Q1 2022 | $7,950,000 | -43.5% | 398,109 | -50.5% | 0.03% | -42.9% |
| Q4 2021 | $14,060,000 | +40.7% | 803,900 | -36.9% | 0.06% | +27.3% |
| Q3 2021 | $9,996,000 | -20.0% | 1,275,000 | +4.9% | 0.04% | -21.4% |
| Q2 2021 | $12,502,000 | -8.8% | 1,215,000 | +15.9% | 0.06% | -12.5% |
| Q1 2021 | $13,709,000 | – | 1,048,100 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 1,615,385 | $20,968,000 | 7.24% |
| Consonance Capital Management LP | 1,216,860 | $15,917,000 | 1.70% |
| VR Adviser, LLC | 1,000,000 | $13,080,000 | 1.42% |
| Johnson & Johnson Innovation - JJDC, Inc. | 728,944 | $9,535,000 | 1.24% |
| DAFNA Capital Management LLC | 385,077 | $5,037,000 | 1.20% |
| Ally Bridge Group (NY) LLC | 425,000 | $5,559,000 | 1.07% |
| Orbimed Advisors | 7,232,856 | $94,606,000 | 0.88% |
| Avidity Partners Management LP | 2,230,000 | $29,168,000 | 0.81% |
| Altium Capital Management LP | 142,289 | $1,861,000 | 0.52% |
| Nantahala Capital Management | 395,875 | $5,178,000 | 0.15% |